CTSL and rheumatoid arthritis: In addition, experimental observations demonstrate that intracellular C3 activation by cathepsin L is dysregulated in T cells from patients with RA, and contributes to Th1 hyperactivity, but can be normalized via a cell‐permeable cathepsin L inhibitor 54.